Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 23.82x is 91% below its estimated 1-year average of 271.27x, near the low end of its estimated 1-year range (23.82x–805.40x).
As of 2026-10-06T17:37:01.063Z.
Calculation as of: 2026-10-06T17:37:01.063Z.
Quote observation: 2026-10-06T17:35:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5a4a1852cf81cc3bdb1e5d7e5b94f2a11abdcd35c6fdd639146ba2a4a55dbff9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
23.82x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.30x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+453.95%
vs the sector median at left
Jupiter Neurosciences, Inc.
Market Cap
$1.31M
EV/Sales Ratio
23.82x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | $1.31M | 23.82x | N/A | N/A | N/A |
| NewcelX Ltd. (NCEL)vs › | $1.32M | N/A | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.34M | N/A | N/A | N/A | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | N/A | N/A | N/A | N/A |
| NEXGEL, Inc. (NXGL)vs › | $1.44M | 0.70x | 1.00x | 2.40x | 3.38x |
| INVO Fertility, Inc. (IVF)vs › | $1.44M | 0.22x | 0.55x | 1.65x | 4.41x |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.16M | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | 0.33x | 0.51x | 0.45x | 1.23x |
| Curis, Inc. (CRIS)vs › | $1.48M | N/A | 0.94x | 2.21x | 9.57x |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | N/A | 0.01x | 35696307.79x | 35696307.79x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 24.37x |
| 2026-10-02 | 25.49x |
| 2026-10-01 | 25.06x |
| 2026-09-30 | 24.54x |
| 2026-09-29 | 25.75x |
| 2026-09-28 | 25.14x |
| 2026-09-25 | 26.52x |
| 2026-09-24 | 28.42x |
| 2026-09-23 | 29.11x |
| 2026-09-22 | 29.20x |
| 2026-09-21 | 28.25x |
| 2026-09-18 | 28.16x |
| 2026-09-17 | 29.45x |
| 2026-09-16 | 28.76x |
| 2026-09-15 | 29.45x |
| 2026-09-14 | 32.90x |
| 2026-09-11 | 29.80x |
| 2026-09-10 | 30.66x |
| 2026-09-09 | 30.14x |
| 2026-09-08 | 30.06x |
| 2026-09-04 | 31.78x |
| 2026-09-03 | 31.61x |
| 2026-09-02 | 33.07x |
| 2026-09-01 | 32.38x |
| 2026-08-31 | 34.02x |
| 2026-08-28 | 39.54x |
| 2026-08-27 | 45.66x |
| 2026-08-26 | 46.69x |
| 2026-08-25 | 48.07x |
| 2026-08-24 | 52.29x |
| 2026-08-21 | 56.95x |
| 2026-08-20 | 48.07x |
| 2026-08-19 | 44.88x |
| 2026-08-18 | 47.12x |
| 2026-08-17 | 48.16x |
| 2026-08-14 | 121.97x |
| 2026-08-13 | 130.80x |
| 2026-08-12 | 114.65x |
| 2026-08-11 | 115.69x |
| 2026-08-10 | 122.78x |
| 2026-08-07 | 120.34x |
| 2026-08-06 | 126.50x |
| 2026-08-05 | 128.24x |
| 2026-08-04 | 151.37x |
| 2026-08-03 | 148.23x |
| 2026-07-31 | 139.52x |
| 2026-07-30 | 146.02x |
| 2026-07-29 | 147.42x |
| 2026-07-28 | 156.72x |
| 2026-07-27 | 159.97x |
| 2026-07-24 | 166.48x |
| 2026-07-23 | 194.49x |
| 2026-07-22 | 213.31x |
| 2026-07-21 | 209.01x |
| 2026-07-20 | 204.95x |
| 2026-07-17 | 211.46x |
| 2026-07-16 | 212.73x |
| 2026-07-15 | 216.68x |
| 2026-07-14 | 216.22x |
| 2026-07-13 | 219.47x |
| 2026-07-10 | 226.56x |
| 2026-07-09 | 231.91x |
| 2026-07-08 | 229.12x |
| 2026-07-07 | 249.11x |
| 2026-07-06 | 253.87x |
| 2026-07-02 | 255.50x |
| 2026-07-01 | 248.53x |
| 2026-06-30 | 247.83x |
| 2026-06-29 | 244.11x |
| 2026-06-26 | 305.13x |
| 2026-06-25 | 267.36x |
| 2026-06-24 | 281.65x |
| 2026-06-23 | 266.77x |
| 2026-06-22 | 261.54x |
| 2026-06-18 | 268.52x |
| 2026-06-17 | 261.20x |
| 2026-06-16 | 265.96x |
| 2026-06-15 | 266.31x |
| 2026-06-12 | 269.56x |
| 2026-06-11 | 260.73x |
| 2026-06-10 | 257.24x |
| 2026-06-09 | 263.17x |
| 2026-06-08 | 262.47x |
| 2026-06-05 | 272.12x |
| 2026-06-04 | 283.39x |
| 2026-06-03 | 279.91x |
| 2026-06-02 | 303.62x |
| 2026-06-01 | 289.79x |
| 2026-05-29 | 284.21x |
| 2026-05-28 | 313.38x |
| 2026-05-27 | 270.14x |
| 2026-05-26 | 261.54x |
| 2026-05-22 | 268.40x |
| 2026-05-21 | 297.11x |
| 2026-05-20 | 239.70x |
| 2026-05-19 | 339.99x |
| 2026-05-18 | 350.68x |
| 2026-05-15 | 355.68x |
| 2026-05-14 | 622.49x |
| 2026-05-13 | 601.84x |
| 2026-05-12 | 592.15x |
| 2026-05-11 | 601.63x |
| 2026-05-08 | 596.15x |
| 2026-05-07 | 613.85x |
| 2026-05-06 | 643.99x |
| 2026-05-05 | 640.19x |
| 2026-05-04 | 707.20x |
| 2026-05-01 | 686.55x |
| 2026-04-30 | 669.48x |
| 2026-04-29 | 639.14x |
| 2026-04-28 | 652.20x |
| 2026-04-27 | 643.14x |
| 2026-04-24 | 686.76x |
| 2026-04-23 | 679.39x |
| 2026-04-22 | 779.27x |
| 2026-04-21 | 805.40x |
| 2026-04-20 | 797.18x |
| 2026-04-17 | 761.15x |
| 2026-04-16 | 700.46x |
| 2026-04-15 | 699.62x |
| 2026-04-14 | 692.03x |
| 2026-04-13 | 700.88x |
| 2026-04-10 | 700.46x |
| 2026-04-09 | 676.02x |
| 2026-04-08 | 658.74x |
| 2026-04-07 | 623.34x |
| 2026-04-06 | 609.22x |
| 2026-04-02 | 652.84x |
